Pfizer Reports Positive Topline Results from Phase 3 Trial Comparing XALKORI(R) (crizotinib) to Chemotherapy in Previously Untreated East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)

… worldwide.1 About Non-Small Cell Lung Cancer Worldwide, lung cancer is the leading cause … patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic … targeted therapy in non-small cell lung cancer: potential role of cetuximab. Biologics …